AAAAAA
Results:
1-24
|
Results: 24
Authors:
EATOCK MM
ANTHONY DA
WILSON P
SOUKOP M
SMITH M
EVANS TRJ
Citation: Mm. Eatock et al., PRELIMINARY-RESULTS OF A DOSE-FINDING STUDY OF TOMUDEX WITH CISPLATINAND EPIRUBICIN AS FIRST-LINE THERAPY FOR METASTATIC OR UNRESECTABLE GASTRIC AND ESOPHAGEAL ADENOCARCINOMA, Annals of oncology, 9, 1998, pp. 235-235
Authors:
EVANS TRJ
DALGLEISH AG
CARMICHAEL J
DIFFLEY J
DEBONO J
ELLARD S
OSTERWALDER B
Citation: Trj. Evans et al., A PHASE-I STUDY OF ONO-4007 IN PATIENTS WITH ADVANCED AND OR METASTATIC CANCER/, Annals of oncology, 9, 1998, pp. 316-316
Authors:
DALHOFF K
ASTRUP L
BACHHANSEN J
BURCHARTH F
HAAHR HLO
HAMBERG KJ
EVANS TRJ
LOFTS F
MOLLER S
RANEK L
SKOVSGAARD T
STEWARD WP
Citation: K. Dalhoff et al., SEOCALCITOL (EB-1089), A VITAMIN-D ANALOG, IN HEPATOCELLULAR-CARCINOMA, Hepatology, 28(4), 1998, pp. 257-257
Authors:
GOGAS H
LOFTS FJ
EVANS TRJ
DARYANANI S
MANSI JL
Citation: H. Gogas et al., ARE SERIAL MEASUREMENTS OF CA19-9 USEFUL IN PREDICTING RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH INOPERABLE ADENOCARCINOMA OF THE PANCREAS, British Journal of Cancer, 77(2), 1998, pp. 325-328
Authors:
EVANS TRJ
MANSI JL
MORGAN DAL
GYI KM
BANHAM SW
MILROY R
Citation: Trj. Evans et al., A PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Oncology Reports, 4(6), 1997, pp. 1337-1341
Authors:
EVANS TRJ
FAIRCLOTH M
DEERY ARS
THOMAS VA
TURNER AJC
DALGLEISH AG
Citation: Trj. Evans et al., ANALYSIS OF K-RAS GENE-MUTATIONS IN HUMAN PANCREATIC-CANCER CELL-LINES AND IN BILE SAMPLES FROM PATIENTS WITH PANCREATIC AND BILIARY CANCERS, Oncology Reports, 4(6), 1997, pp. 1373-1381
Authors:
ONEILL VJ
EVANS TRJ
KAYE SB
Citation: Vj. Oneill et al., AN AUDIT OF HICKMAN LINE COMPLICATIONS IN PATIENTS WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 235-235
Authors:
LOFTS FJ
EVANS TRJ
MANSI JL
GLEES JP
KNIGHT MJ
Citation: Fj. Lofts et al., BILE-DUCT STENTS - IS THERE AN INCREASED RATE OF COMPLICATIONS IN PATIENTS RECEIVING CHEMOTHERAPY, European journal of cancer, 33(2), 1997, pp. 209-213
Authors:
GOGAS H
LOFTS FJ
EVANS TRJ
MILLARD FJC
WILSON R
MANSI JL
Citation: H. Gogas et al., OUTPATIENT TREATMENT WITH EPIRUBICIN AND ORAL ETOPOSIDE IN PATIENTS WITH SMALL-CELL LUNG-CANCER, British Journal of Cancer, 76(5), 1997, pp. 639-642
Authors:
EVANS TRJ
MANSI JL
ADAM EJ
Citation: Trj. Evans et al., PRIMARY ISOLATED EPITHELIOID HEMANGIOENDOTHELIOMA OF A LUMBAR VERTEBRA, Oncology Reports, 3(4), 1996, pp. 751-752
Authors:
HARPER CL
EVANS TRJ
MANSI JL
Citation: Cl. Harper et al., AN UNUSUAL PRESENTATION OF HODGKINS-DISEASE, Oncology Reports, 3(2), 1996, pp. 273-275
Authors:
LOFTS FJ
EVANS TRJ
WASTNAGE R
MANSI JL
Citation: Fj. Lofts et al., MAGNESIUM SUPPLEMENTS WITH CISPLATIN CHEMOTHERAPY, European journal of cancer, 32A(3), 1996, pp. 556-557
Authors:
EVANS TRJ
MANSI JL
BEVAN DH
Citation: Trj. Evans et al., TROUSSEAUS-SYNDROME IN ASSOCIATION WITH OVARIAN-CARCINOMA, Cancer, 77(12), 1996, pp. 2544-2549
Authors:
EVANS TRJ
LOFTS FJ
MANSI JL
GLEES JP
DALGLEISH AG
KNIGHT MJ
Citation: Trj. Evans et al., A PHASE-II STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL WITH CISPLATINAND EPIRUBICIN IN INOPERABLE PANCREATIC-CANCER, British Journal of Cancer, 73(10), 1996, pp. 1260-1264
Authors:
EVANS TRJ
HARPER CL
BEVERIDGE IG
WASTNAGE R
MANSI JL
Citation: Trj. Evans et al., A RANDOMIZED STUDY TO DETERMINE WHETHER ROUTINE INTRAVENOUS MAGNESIUMSUPPLEMENTS ARE NECESSARY IN PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY WITH CONTINUOUS-INFUSION 5-FLUOROURACIL, European journal of cancer, 31A(2), 1995, pp. 174-178
Authors:
EVANS TRJ
Citation: Trj. Evans, CLINICAL-APPLICATIONS OF NEW AROMATASE INHIBITORS, Critical reviews in oncology/hematology, 16(2), 1994, pp. 129-143
Authors:
EVANS TRJ
ROWLANDS MG
SAHOTA SS
COOMBES RC
Citation: Trj. Evans et al., LACK OF INHIBITION OF PLACENTAL ESTRONE SULFATASE AND AROMATASE ENZYMES BY VITAMIN-D-3 AND ITS ANALOGS, Journal of steroid biochemistry and molecular biology, 48(5-6), 1994, pp. 563-566
Authors:
EVANS TRJ
MANSI JL
BULL R
FALLOWFIELD ME
BEVAN DH
PATH MRC
HARMER CL
DALGLEISH AG
Citation: Trj. Evans et al., EOSINOPHILIC FOLLICULITIS OCCURRING AFTER BONE-MARROW AUTOGRAFT IN A PATIENT WITH NON-HODGKINS-LYMPHOMA, Cancer, 73(10), 1994, pp. 2512-2514
Authors:
EVANS TRJ
ROWLANDS MG
LAW M
COOMBES RC
Citation: Trj. Evans et al., INTRATUMORAL ESTRONE SULFATASE ACTIVITY AS A PROGNOSTIC MARKER IN HUMAN BREAST-CARCINOMA, British Journal of Cancer, 69(3), 1994, pp. 555-561
Authors:
SEYMOUR MT
MANSI JL
GALLAGHER CJ
GORE ME
HARPER PG
EVANS TRJ
EDMONDS PM
SLEVIN ML
Citation: Mt. Seymour et al., PROTRACTED ORAL ETOPOSIDE IN EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY IN PATIENTS WITH RELAPSED OR PLATINUM-RESISTANT DISEASE, British Journal of Cancer, 69(1), 1994, pp. 191-195
Authors:
CHANDER SK
SAHOTA SS
EVANS TRJ
LUQMANI YA
Citation: Sk. Chander et al., THE BIOLOGICAL EVALUATION OF NOVEL ANTIESTROGENS FOR THE TREATMENT OFBREAST-CANCER, Critical reviews in oncology/hematology, 15(3), 1993, pp. 243-269
Authors:
EVANS TRJ
ROWLANDS MG
LUQMANI YA
CHANDER SK
COOMBES RC
Citation: Trj. Evans et al., DETECTION OF BREAST CANCER-ASSOCIATED ESTRONE SULFATASE IN BREAST-CANCER BIOPSIES AND CELL-LINES USING POLYMERASE CHAIN-REACTION, Journal of steroid biochemistry and molecular biology, 46(2), 1993, pp. 195-201
Authors:
EVANS TRJ
ROWLANDS MG
SILVA MC
LAW M
COOMBES RC
Citation: Trj. Evans et al., PROGNOSTIC-SIGNIFICANCE OF AROMATASE AND ESTRONE SULFATASE ENZYMES INHUMAN BREAST-CANCER, Journal of steroid biochemistry and molecular biology, 44(4-6), 1993, pp. 583-587
Authors:
MANSI JL
EVANS TRJ
SMITH A
OAKLEY C
WASTNAGE R
DALGLEISH A
Citation: Jl. Mansi et al., SHOULD WE BE USING 5-HT3 ANTAGONISTS AS 1ST LINE ANTIEMETIC THERAPY IN CISPLATIN-BASED CHEMOTHERAPY, Annals of oncology, 4(5), 1993, pp. 433-434
Risultati:
1-24
|